País: Jordânia
Língua: inglês
Origem: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Nadroparin Calcium 1900 IU Axa/0.2ml
مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd
B01AB06
Nadroparin Calcium 1900 IU Axa/0.2ml
1900 IU Axa/0.2ml
10 PFS/0.2ml
Aspen Notre Dame De Bondeville (فرنسا)
23.12 :سعر الجمهور + الضريبة
FRAXIPARINE ™ /FRAXIPARINE FORTE ™ /FRAXODI ™ NADROPARIN QUALITATIVE AND QUANTITATIVE COMPOSITION _FRAXIPARINE _ [NADROPARIN CALCIUM SOLUTION FOR INJECTION (9,500 ANTI-XA IUPH.EUR./ML)] _PRE-FILLED SYRINGES:_ - 0.2 ml of solution equivalent to 1,900 anti-Xa IU - 0.3 ml of solution equivalent to 2,850 anti-Xa IU - 0.4 ml of solution equivalent to 3,800 anti-Xa IU. _GRADUATED PRE-FILLED SYRINGES:_ - 0.6 ml of solution equivalent to 5,700 anti-Xa IU - 0.8 ml of solution equivalent to 7,600 anti-Xa IU - 1 ml of solution equivalent to 9,500 anti-Xa IU. _MULTI DOSE VIALS:_ - 2 ml of solution equivalent to 19,000 anti-Xa IU - 5 ml of solution equivalent to 47,500 anti-Xa IU - 15 ml of solution equivalent to 142,500 anti-Xa IU. _FRAXIPARINE_ _FORTE_ AND _FRAXODI_ [NADROPARIN CALCIUM DOUBLE STRENGTH SOLUTION FOR INJECTION (19,000 ANTI-XA IU PH.EUR./ML)] _GRADUATED PRE-FILLED SYRINGES:_ - 0.6 ml of solution equivalent to 11,400 anti-Xa IU - 0.8 ml of solution equivalent to 15,200 anti-Xa IU - 1 ml of solution equivalent to 19,000 anti-Xa IU. _MULTI-DOSE VIALS:_ - 5 ml of solution equivalent to 95,000 anti-Xa IU. - 15 ml of solution equivalent to 285,000 anti-Xa IU. PHARMACEUTICAL FORM Solution for injection. CLINICAL PARTICULARS INDICATIONS _FRAXIPARINE [NADROPARIN CALCIUM SOLUTION FOR INJECTION (9,500 ANTI-XA IU/ML)]_ The prophylaxis of thromboembolic disorders, such as: - those associated with general or orthopaedic surgery - those in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure), hospitalised in intensive care unit. The treatment of thromboembolic disorders. The prevention of clotting during haemodialysis. The treatment of unstable angina and non-Q wave myocardial infarction. _FRAXIPARINE FORTE _AND _FRAXODI_ _[NADROPARIN CALCIUM DOUBLE STRENGTH SOLUTION _ _FOR INJECTION (19,000 ANTI-XA IU/ML)]_ The treatment of thromboembolic disorders. DOSAGE AND ADMINISTRATION Particular attention should be paid to the specific dosing instructions for each proprietary Low M Leia o documento completo